Login / Signup
Does dosing frequency of anti-CD20 therapies blunt vaccine responses and increase COVID-19 susceptibility in patients with multiple sclerosis?
Jagannadha Avasarala
Published in:
British journal of clinical pharmacology (2024)
Keyphrases
</>
coronavirus disease
sars cov
trauma patients
nk cells